Eyebright Medical Technology (Beijing) Co., Ltd. (SHA: 688050)

Market Cap	17.66B
Revenue (ttm)	1.36B
Net Income (ttm)	369.60M
Shares Out	189.54M
EPS (ttm)	1.95
PE Ratio	47.81
Forward PE	30.54
Dividend	0.27 (0.30%)
Ex-Dividend Date	Jun 5, 2024

Volume	2,392,672
Open	90.09
Previous Close	92.29
Day's Range	89.88 - 93.93
52-Week Range	65.17 - 198.47
Beta	0.51
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 25, 2024

About Eyebright Medical Technology (Beijing)

Eyebright Medical Technology (Beijing) Co., Ltd. develops a range of ophthalmic medical products. Its products include surgical implants and instruments, equipment, optometric lenses, eye drops, etc. for the treatment of ophthalmic diseases and vision problems, such as cataract, glaucoma, refractive errors, and other ophthalmic diseases. The company was founded in 2010 and is based in Beijing, China.

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2010
• Employees: 2,074
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688050

Financial Performance

In 2023, Eyebright Medical Technology (Beijing)'s revenue was 951.18 million, an increase of 64.14% compared to the previous year's 579.50 million. Earnings were 303.98 million, an increase of 30.63%.